
Sign up to save your podcasts
Or


Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Join us as we review long-term outcomes from a recently published trial on prostate-specific antigen (PSA) testing and prostate cancer mortality. Learn how updated evidence informs shared decision-making and balances early detection with potential harms. Equip yourself to guide patients through nuanced discussions on PSA testing’s limitations, mortality data, and meaningful clinical impact.
Episode resource links:
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at [email protected]
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
By Pri-Med4.5
8585 ratings
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Join us as we review long-term outcomes from a recently published trial on prostate-specific antigen (PSA) testing and prostate cancer mortality. Learn how updated evidence informs shared decision-making and balances early detection with potential harms. Equip yourself to guide patients through nuanced discussions on PSA testing’s limitations, mortality data, and meaningful clinical impact.
Episode resource links:
Guest: Robert A. Baldor MD, FAAFP
Music Credit: Matthew Bugos
Thoughts? Suggestions? Email us at [email protected]
The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

135 Listeners

706 Listeners

500 Listeners

258 Listeners

298 Listeners

265 Listeners

3,379 Listeners

1,146 Listeners

197 Listeners

91 Listeners

515 Listeners

363 Listeners

253 Listeners

377 Listeners

325 Listeners